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expression of the cloned toxin gene indicates that the production of
the proposed vaccine strains is a viable prospect.
In addition, we would like to report an observation which may be
of importance when considering the evolution of the V. cholerae
enterotoxin. When radiolabelled V. cholerae cloned DNA (17 kb)
was hybridised back to restriction fragments of chromosomal DNA
separated by gel electrophoresis, two fragments hybridised to the
probe. Similar results were also seen when the A subunit of the LT
gene was used as probe. However, only one fragment was detected
when the B subunit encoding DNA of the LT gene was used. This
suggests that there is, within the chromosome, another gene with
almost identical sequence which could, therefore, be expected to
code for a protein of similar function-i.e., catalysing ADP
ribosylation. This observation accords with biochemical studies of
Fernandez et al. who showed that V. cholerae contains more than
one ADP ribosylating enzyme. One might, therefore, speculate that
the sequence encoding the A subunit of cholera toxin may have
arisen by mutation following duplication of the gene specifying a
normal host cell function. Possession of the toxin would have given
the organism a selective advantage over non-toxigenic forms. We are
now investigating this possibility and are developing the candidate
vaccine strains mentioned in this letter.
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PHENOXY HERBICIDES, TRICHLOROPHENOLS, AND
SOFT-TISSUE SARCOMAS
SIR,-Your May 8 editorial rightly draws attention to the presence
of the toxic contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) in both the herbicide 2,4,5-T (2,4,5-trichlorophenoxy-
acetic acid) and in the related 2,4,5-trichlorophenol. TCDD, as the
editorial points out, is reported to have genotoxic effects in
microbial assays and is also tumorigenic in rats.
Your editorial also notes that TCDD is not seen in the
herbicide 2,4-D (2,4-dichlorophenoxyacetic acid). This is true.
However, there are other chlorinated dioxins in 2,4-D. A
recent report5 says that 2,7-dichloro, 1,3,7-dichloro, and
1,3,6,8/1,3,7,9-tetrachlorodibenzo-p-dioxins are present in 2,4-D
ester formulations sold in Canada. The concentrations for the
2,7-dichloro and the 1,3,7-trichloro compounds and for the two
tetrachloro isomers are reported as 0 - 11-23’ 8, 0 - 035-2’ 45, and
0 ’12-8’ 73 parts per million, respectively.
Dr Coggon and professor Acheson (May 8, p. 1057) review the
evidence for a link between exposure to 2,4,5-T and soft tissue
sarcoma and conclude, cautiously, that there may be one. This
evidence includes a paper by Hardell et al. who reported an
increased risk from malignant lymphoma in workers exposed to
several other chlorinated herbicides, including 2,4-D. Thus,
although 2,4-D does not have measurable concentrations of TCDD,
it might not be entirely in the clear, if Hardell’s findings are correct.
We have investigated the mutagenic properties of several
chlorinated dioxin isomers, using the cell transformation assay. In
4. Fernandes PB, Welsh KM, Bayer ME. Characterisation of membrane bound
nicotinamide adenosine dinucleotide glycohydrolases of Vibrio cholerae. J Biol Chem
1979; 254: 9254-61.
5. Cochrane WP, Singh J, Miles W, Wakeford B. Determination of chlorinated dibenzo-
p-dioxin contaminants in 2,4-D products by gas-chromatography-mass
spectrometric techniques. J Chrom 1981; 217: 289-99.
6. Hardell L, Eriksson M, Lenner P, Lundgreen E Malignant lymphoma and exposure to
chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-
control study. Br J Cancer 1981; 43: 169-76.
7. Ashby J, Styles JA, Elliot B, Hay AWM. Cited by Hay A. The chemical scythe. Lessons
of 2,4,5-T and dioxin. New York: Plenum Publishing (in press).
8. Styles JA. A method for detecting carcinogenic organic chemicals using mammalian
cells in culture. Br J Cancer 1977; 36: 558-63.
this assay both 2,8-dichloro and 1,3,7-trichloro dibenzo-p-dioxin
were weakly positive (i.e., weakly mutagenic) whereas two samples
of TCDD were clearly positive. The unsubstituted dibenzo-p-
dioxin and the fully chlorinated octachlorodibenzo-p-dioxin were
both negative in the cell transformation assay. Although we were
unable to test the 2,7-dichloro isomer, the 2,8-dichlorodibenzo-p-
dioxin which we did test is a closely related analogue. A study9
commissioned and published by the National Cancer Institute
concluded that the 2,7-dichloro isomer is probably carcinogenic in
male B3C3FI mice where it caused marginal increased incidences of
combinations of leukaemias and lymphomas, of haemangiosar-
comas and haemangiomas, and of hepatocellular carcinomas and
adenomas. The concentration of chemical required to produce
tumours in this animal (tumours have not been observed in other
species tested so far) is high. ’
As your editorial points out it is most important that the issue of
the link between 2,4,5-T exposure and soft tissue cancer remain
under informed scrutiny. It might also be prudent to widen the net
slightly and look at some other chlorinated herbicides.
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PHENOBARBITONE AND NEONATAL
INTRAVENTRICULAR HAEMORRHAGE
SIR,-Last year we reported promising experience with
phenobarbitone for the prevention of intraventricular haemorrhage
(IVH) in preterm infants.1 We have so far enrolled 105 babies in this
controlled study, which is continuing. Examination of treatment
failures in our first cohort of 60 infants suggested that haemorrhage
was occurring before completion of phenobarbitone loading and
achievement of anticonvulsant serum concentrations. Therefore,
after our first report we modified the dose schedule of treated infants
to allow for earlier drug loading. Infants receiving assisted
ventilation are given phenobarbitone in a single 20 mg/kg loading
dose intravenously over 10-15 min. Spontaneously breathing
infants are given two 10 mg/kg intravenous doses 4 h apart. Most of
the treated infants received the first dose within an hour of birth; all
were treated before 6 h of age. In all instances maintenance doses of
2 - 5 mg/kg (intravenously) are started 12 h after loading is completed
and continued for 7 days. Serum levels of phenobarbitone are
measured and dosage adjusted when necessary to maintain
concentrations in the serum of 20-30 pg/ml.
The table shows the results of the effect of phenobarbitone on the
incidence of all grades of IVH. We continue to find a significant
reduction in the incidence of IVH in treated infants. The
distribution of IVH by grade2 is also shown. The major impact of
treatment appears to be a reduction in the number of haemorrhages
(grades I, II, and III) not extending into brain parenchyma.
Hope et al. and Morgan and Cooke4 have found no beneficial
effect of phenobarbitone on IVH. The major differences between
our investigation and theirs are time of first dose, route of
administration, and duration of therapy. Morgan and Cooke gave a
single intramuscular dose of 20 mg/kg without further treatment.
Although the phenobarbitone was usually administered within the
first 2 h of life, serum levels were not provided to document the rate
and efficacy of absorption from the intramuscular site. Hope et al.
gave two 10 mg/kg doses of phenobarbitone parenterally 12 h apart.
The timing of the first dose varied from 2 to 46 h of life. The route of
parenteral administration (intravenous or intramuscular) was not
9. Anon Bioassay of 2,7-dichlorodibenzo-p-dioxin (DCDD) for possible carcinogenicity.
Nat Cancer Inst Carcinogenesis Tech Rep Ser 1979, no 123.
1. Donn SM, Roloff DW, Goldstein GW. Prevention of intraventricular haemorrhage in
preterm infants by phenobarbitone: a controlled trial Lancet 1981; ii: 215-17.
2. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of
subependymal and intraventricular hemorrhage. a study of infants with
birthweights less than 1500 g. J Pediatr 1978; 92: 529-34
3. Hope PL, Stewart AL, Thorburn RJ, et al. Failure of phenobarbitone to prevent
intraventricular haemorrhage in small preterm infants. Lancet 1982; i: 444-45
4. Morgan MEI, Cooke RWI. Failure of phenobarbitone to prevent neonatal
intraventricular haemorrhage. Lancet 1982, i: 558-59.
1241
INCIDENCE AND DISTRIBUTION OF IVH
X2=lOo71, p<O’OO5.
stated. Maintenance therapy was discontinued at 120 h of age.
Serum phenobarbitone levels were not provided.
Our reduction in the incidence of IVH in treated babies may be
related to a more rapid achievement of peak serum levels which were
then maintained for 7 days. Additional controlled investigations are
clearly needed to test the hypothesis that early and rapid
achievement of anticonvulsant serum levels of phenobarbitone may
reduce the incidence of IVH in preterm infants.
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VALIDITY OF TRANSCUTANEOUS PO2 MONITORING
AS COMPARED WITH INTRA-ARTERIAL PO2
MONITORING IN NEWBORN INFANTS
SIR,-The transcutaneous P02 electrode (tcP02) has become a
frequently used tool in the neonatal ward since it was introduced
commercially in the mid-1970s. tcPC02 electrodes are now
commercially available too, and could be used as frequently as the
P02 electrode is, especially if the two electrodes can be combined.
Interest in this subject is illustrated by the holding of international
meetings devoted solely to transcutaneous gas monitoring (San
Francisco 1977, Marburg 1978, Zurich 1981).
We have monitored oxygen with a transcutaneous sensor and a
surface heparinised intra-arterial P02 electrode simultaneously in
infants and found that the transcutaneous electrode often
underestimated Pa02, when the arterial Pa02 was above 9 kPa (67
mm Hg) (figure). Furthermore, when infants were distressed, as
indicated by increased plasma catecholamine levels, the tcP02 was
lower than the Pa02, probably because of reduced skin perfusion.
The transcutaneous oxygen sensor almost lost its sensitivity when
compared with a rising Pa02, but the breakpoint could not be
predicted, and was obviously a function of plasma catecholamine
concentration. Jensen et al. have demonstrated a successively
decreased ratio between tcP02 and Pa02 as a function of raising
plasma noradrenaline levels in the asphyxiated fetal sheep. A poor
correlation between tcPOo and Pa02 in severely sick infants has
previously been reported. ,3
Companies selling tcP02 electrodes and the proceedings of
international symposia give the impression that the tcP02 when
used on infants is very closely correlated with Pa02. Several graphs
have been presented with r values close to 0 - 9, but in evaluations of
individual measurements, the same readout on the tcP02 monitor
corresponds with Pa02 values which can vary within a wide
range. 3,4 A close correlation might hold for ideal clinical conditions
and for high electrode temperatures, but the method is not always
reliable in the routine care of sick neonates, as indicated above.
Transcutaneous measurements should never be trusted alone:
1. Jensen A, K&uuml;nzel W, Kastendieck E. Transcutaneous PO2 and norepinephrine release
in the fetal sheep fetus after repetitive reduction of uterine blood flow. Paper read at
2nd International Symposium on Continuous Transcuraneous Blood Gas
Monitoring (Z&uuml;rich, Oct. 14-16, 1981).
2. Peabody JL, Gregory GA, Willis MM, Tooley WH. Transcutaneous oxygen tension in
sick infants. Am Rev Resp Dis 1978, 118: 83-87.
3. Bompard Y, Beaufils F, Azancot A, Asensi D. Continuous transcutaneous PO2
monitoring in vital distress of children Birth Defects: Orig Article Ser 1979, 15:
383-86.
4. Yahav J, Mindorff C, Levison H. The validity of the transcutaneous oxygen tension
method in children with cardiorespiratory problems. Am Rev Resp Dis 1981; 124:
586-87.
Corresponding readouts from continuous intra-arterial P02
recorders and tcPO2 monitor on eight newborn children in
intensive care.
The intra-arterial P02 sensor (Hoffman-La Roche, Basle, Switzerland) was
surface heparinised (IRD Biomaterial AB, Stockholm, Sweden). The tcP02
sensor (Radiometer, Copenhagen, Denmark) was placed on the same level as
the tip of the intra-arterial P02 sensor, to avoid influence from the arterial
ductus. The oxygen atmosphere of the infants was determined on clinical
grounds. When the intra-arterial P02 became high the fraction of oxygen was
lowered in order to avoid dangerously high Pa02 values.
continuous intravascular recordings with non-thrombogenic
sensors should be preferred for monitoring Pa02 in severely
distressed infants.
The study was approved by the ethical committee at the Karolinska
Hospital, Stockholm.
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IgA AND PRETERM MILK
SiR,-Recent work suggests that the milk of mothers who have
delivered preterm infants, so called preterm milk (PTM), differs in
constitution from normal-term milk (TM),1,2 which is the type of
milk donated to human milk banks. We have identified an
immunological difference between PTM and TM which may be
relevant to the management of high-risk low-birthweight infants.
As part of an immunological study (to be published in full) of 115
samples of expressed TM or PTM from healthy mothers in the first
10 days after delivery, we found that during the first 5 post-partum
days total milk IgA concentrations (determined by both rocket
immunoelectrophoresis and reverse passive haemagglutination)
were significantly higher in PTM than in TM (see figure). These
findings accord with those of Gross et al. (but not with those of
1. Atkinson SA, Bryan MH, Anderson BH. Human milk. Difference in nitrogen
concentration in milk from mothers of term and premature infants. J Pediatr 1978;
93: 67-69.
2. Lemons JA, Moyle L, Hall D, Simmons M. Differences in the composition of preterm
and term human milk during early lactation. Pediatr Res 1982; 16: 113-17.
3 Gross SJ, Buckley RH, Wakil SS, McAllister DC, David RJ, Faix RG Elevared IgA
concentration in milk produced by mothers delivered of preterm infants. J Pediatr
1981; 99: 389-93.
